https://www.selleckchem.com/pr....oducts/BMS-754807.ht
The integration of physiological and molecular targeted nuclear imaging for real-time delivery of targeted theranostics in the interventional laboratory may enable more personalized care for a wide variety of cardiovascular procedures and improve patient outcomes. To review cardiovascular outcomes (CVE) in systemic lupus erythematosus (SLE) that evolves over time. Inception cohorts now report long-term data, and large population registries add to our knowledge. Mortality and cardiovascular morbidity remain high with a risk ratio of 2